Colgate-Palmolive (NYSE:CL) Stock Holdings Lessened by SVB Wealth LLC

SVB Wealth LLC lessened its holdings in shares of Colgate-Palmolive (NYSE:CL) by 7.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 33,963 shares of the company’s stock after selling 2,804 shares during the period. SVB Wealth LLC’s holdings in Colgate-Palmolive were worth $2,707,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. &PARTNERS raised its position in shares of Colgate-Palmolive by 0.7% during the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after purchasing an additional 129 shares during the period. West Branch Capital LLC lifted its stake in Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after buying an additional 132 shares during the last quarter. Gladstone Institutional Advisory LLC increased its holdings in shares of Colgate-Palmolive by 2.1% in the 1st quarter. Gladstone Institutional Advisory LLC now owns 6,329 shares of the company’s stock worth $476,000 after acquiring an additional 133 shares during the period. First Foundation Advisors lifted its position in Colgate-Palmolive by 2.7% in the 3rd quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock valued at $372,000 after purchasing an additional 136 shares during the last quarter. Finally, Waldron Private Wealth LLC boosted its stake in Colgate-Palmolive by 2.7% during the 3rd quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after purchasing an additional 140 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.7 %

Shares of NYSE:CL opened at $86.77 on Thursday. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The stock has a market capitalization of $71.32 billion, a price-to-earnings ratio of 31.21, a PEG ratio of 3.28 and a beta of 0.42. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $90.37. The company has a 50 day moving average price of $86.97 and a 200 day moving average price of $80.63.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. The company had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.77 EPS. On average, research analysts anticipate that Colgate-Palmolive will post 3.49 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 69.06%.

Analyst Ratings Changes

Several equities research analysts have commented on CL shares. Evercore ISI raised their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research note on Monday, April 8th. The Goldman Sachs Group initiated coverage on Colgate-Palmolive in a research report on Friday, March 1st. They set a “buy” rating and a $93.00 price target for the company. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. Stifel Nicolaus upped their price objective on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Finally, Citigroup increased their target price on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $89.50.

Insiders Place Their Bets

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 69,948 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the transaction, the chief executive officer now directly owns 286,881 shares in the company, valued at $24,161,117.82. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, CEO Noel R. Wallace sold 69,948 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the sale, the chief executive officer now owns 286,881 shares in the company, valued at $24,161,117.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director C Martin Harris sold 2,760 shares of Colgate-Palmolive stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the transaction, the director now owns 19,272 shares in the company, valued at approximately $1,628,484. The disclosure for this sale can be found here. In the last quarter, insiders have sold 232,371 shares of company stock worth $19,505,099. Company insiders own 0.37% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.